mail
admin@editorjprims.com
whatsapp
+919343055451
e-ISSN: 3049-1681
logo

Journal of Pharmaceutical Research and Integrated Medical Sciences

📢 Latest Update: New special issue call for papers on "Emerging Technologies in Research" - Submit by March 31, 2025

📢 Latest Update: New special issue call for papers on "Emerging Technologies in Research" - Submit by March 31, 2025

December-2024

Volume 1, Issue 1 - $2024

Volume 1 Issue 1 Cover

Issue Details:

Volume 1 Issue 1
Published:Invalid Date

Editorial: December-2024

Welcome to the 2024 issue of Journal of Pharmaceutical Research and Integrated Medical Sciences. This issue showcases the remarkable breadth and depth of contemporary research across multiple disciplines. From cutting-edge applications of machine learning in climate science to the revolutionary potential of quantum computing in drug discovery, our featured articles demonstrate the power of interdisciplinary collaboration in addressing global challenges.

We are particularly excited to present research that bridges traditional academic boundaries, reflecting our journal's commitment to fostering innovation through cross-disciplinary dialogue. The integration of artificial intelligence with environmental science, the application of blockchain technology to supply chain management, and the convergence of urban planning with smart city technologies exemplify the transformative potential of collaborative research.

As we continue to navigate an era of rapid technological advancement and global challenges, the research presented in this issue offers both insights and solutions that will shape our future. We thank our authors, reviewers, and editorial board members for their continued dedication to advancing knowledge and promoting scientific excellence.

Dr. Arpan Kumar Tripathi
Editor-in-Chief
Journal of Pharmaceutical Research and Integrated Medical Sciences

Articles in This Issue

Showing 6 of 6 articles
Research PaperID: JPRIMS110004

Preparation, Characterization, and Bio-Efficacy Evaluation of Controlled-Release Carbendazim-Loaded Polymeric Nanoparticles

Arpan Tripathi, Rupesh Soni, Shekhar Verma

This research discusses the bio-efficacy, characterization, and synthesis of polymeric nanoparticles (CNPs) charged with the fungicide carbendazim in controlled-release pest management applications for agriculture. The traditional usage of the broad-spectrum fungicide carbendazim has faced many disadvantages, such as its high toxicity, rapid environmental degradation, and resistance. Problems associated with carbendazim are resolved by CNPs encapsulating it, as the regulated release profile enhances the stability of the fungicide and diminishes its negative impact on the environment. They possessed excellent physicochemical characteristics, such as a stable surface charge of (-25.6 ± 0.9 mV), a high encapsulation efficiency of (82 ± 2%), and an optimal particle size of (150 ± 10 nm), respectively, which were achieved by using a solvent evaporation approach to manufacture the nanoparticles. Carbendazepim release from CNPs presented a slow, steady release over 120 hours and a far lower burst release 77.8% less than the standard formulation. Comparison of the traditional carbendazim against CNPs showed an improvement of 28.6% in bio-efficacy. The wider inhibition zones and better reduction in mycelial growth indicate superior antifungal action. These results highlight the advantages of polymeric nanoparticles as a sustainable and environmentally friendly substitute.

1,605 views
347 downloads

Contributors:

 Arpan Tripathi
,
 Rupesh Soni
,
 Shekhar Verma
Research PaperID: JPRIMS110005

Dietary Patterns and Individualized Approaches to Nutritional Interventions in Type 2 Diabetes

Revendra Parganiha, Hemant Sawarkar

Deficient food arranging is essential for the beginning and headway of type 2 diabetes and is emphatically connected to destroy microbiota dysbiosis. Therefore, this comprehensive review set out to determine the effects of dietary interventions on the gut microbiota and metabolic limits of type 2 diabetics. A growing number of people are living with type 2 diabetes (T2D), and making changes to one's lifestyle may help reverse this trend. We need additional evidence based on practice to fully understand the validity and rationale of these attestations. This observational study used a pretest-posttest design to examine the effects of a 6-month multicomponent short-term bunch-based nutrition and lifestyle mediation program on glycaemic control and the use of glucose-lowering prescription in persuaded type 2 diabetes patients with a body mass index (BMI) >25 kg/m2 in the Netherlands. The evaluation period was February 2015 through Walk 2016. A 6-month multi-component bunch-based program in a normal care setting improved glycaemic control and declined the necessity for glucose-lowering prescription in convinced type 2 diabetes, according to this pilot study. Validating these findings will necessitate a comprehensive investigation.

1,547 views
497 downloads

Contributors:

 Revendra Parganiha
,
 Hemant Sawarkar
Research PaperID: JPRIMS110006

Pharmacological Activities of Essential Oils from Medicinal Plants - A systemic Review

Ashish Kumar Pandey, Neha Sharma

Through an analysis of the oil's phytochemical makeup, the antifungal, insecticidal, and antioxidant capabilities of Haplophyllum tuberculatum essential oil not entirely settled and analyzed. The usage of gas chromatography-mass spectrometry analysis resulted in the discovery of fifty chemicals, with β-Caryophyllene being the major fixing identified among these compounds. The results of the study revealed that HTEO demonstrated a significant level of effectiveness against Aspergillus flavus, as confirmed by a hindrance rate of 87.61% ± 1.71%. The antifungal effects of this substance, then again, were not nearly as intense as the antibacterial effects. Furthermore, the results of the contact and inhalation tests indicated that it had a vital insecticidal action against C. maculatus. This was affirmed by the LC50 values of 30.66 and 40.28 μL/100g, respectively. It was resolved that the essential oil possessed an antioxidant capacity of 869.45 mg AAE/g. This was mostly because of the presence of γ-Terpinyl isobutyrate, which is an antioxidant, as well as γ-Cadinene and p-Cymen-7-ol, which are principally responsible for their antifungal action. With regards to the treatment of illness, the utilization of HTEO as a sustainable and environmentally friendly alternative to synthetic medications is turning into an increasingly prevalent practice.

Essential OilMedicinal PlantsPharmacological ActivitiesHaplophyllum Tuberculatum
1,407 views
586 downloads

Contributors:

 Ashish Kumar Pandey
,
 Neha Sharma
Research PaperID: JPRIMS110007

Advances in Nanotechnology for Targeted Drug Delivery in Central Nervous System

Pratibha Sahu, Revendra Parganiha

Patients who are suffering from illnesses that influence the central nervous system (CNS) struggle with getting medicine because of the presence of two barriers: the blood-cerebrospinal fluid boundary and the intrinsic blood-cerebrum obastruction (BBB). Both of these barriers make it hard to safely give prescription. There are various neurological conditions that are routinely perceived, including Alzheimer's disease, frontotemporal dementia, amyotrophic parallel sclerosis, Parkinson's disease, and Huntington's disease, to give some examples. In addition to these disorders, there are some that can affect the neurological system. Nanotechnology in drug conveyance systems is one therapy strategy that has the possibility to be powerful in the treatment of specific ailments. This is because nanotechnology has the capacity to control the distribution of drugs. To conquer the problems that have been presented and making progress in the conveyance of medications to the central nervous system, various approaches have been created to be successful. This research was completed determined to cast light on late advancements in the field of nanotherapeutics research and the possible consequences of these advancements in the treatment of illnesses that disable the central nervous system. The research was completed with the target of shedding light on these advancements. Another subject that is investigated is the challenges that are experienced while endeavoring to bring nanomedicine from the research facility to the bedside with the end goal of clinical application.

Drug DeliveryCentral Nervous System (CNS)AdvancementNanotechnology
1,804 views
501 downloads

Contributors:

 Pratibha Sahu
,
 Revendra Parganiha
Research PaperID: JPRIMS110008

An Overview of Nanoparticle-Based Approaches for Targeted Therapy in Cardiovascular Diseases

Govind Sharma, Vinay Sagar Verma

Nanoparticle-based medicate conveyance frameworks, moreover known as nano-DDSs, show a promising approach to focused on treatment within the treatment of cardiovascular illnesses (CVDs), which incorporate heart disappointment, arrhythmia, atherosclerosis, and myocardial dead tissue. A diagram of the use of nanoparticles within the conclusion and treatment of cardiovascular infection (CVD) is displayed in this work. The nanoparticles that are examined incorporate natural and inorganic nanoparticles, as well as multifunctional nanoparticles. Nano-DDSs have the capacity to move forward restorative results whereas simultaneously minimising side responses and focusing on particular zones. Usually fulfilled by precisely conveying solutions to atherosclerotic plaques and encompassing tissues. In expansion, these innovations make strides demonstrative capabilities of imaging modalities counting attractive reverberation imaging (MRI) and computed tomography (CT). The application of nanotechnology permits for the determination of issues such as non-specific cytotoxicity, destitute dissolvability, and restricted bioavailability. Both the plausibility of custom fitted sedate conveyance and the advance that has been made in cardiovascular nanomedicine have the potential to upgrade quiet results significantly.

2,110 views
652 downloads

Contributors:

 Govind Sharma
,
 Vinay Sagar Verma
Research PaperID: JPRIMS110009

Mechanisms of Diabetes Mellitus and Cardiovascular Complications and Innovative Treatment Approaches

Arnav Roy, Rashmi chanda

Heart failure can be caused by a number of conditions, including diabetic cardiomyopathy, persistent strain overload, and myocardial localized necrosis. These conditions are associated with both the metabolic disease diabetes mellitus (DM) and atherosclerotic cardiovascular disease (CVD). Pathogenetic mechanisms include altered metabolic profiles, intracellular flagging pathways, energy age, redox state, elevated weakness to ischemia, and extracellular network rebuilding. These mechanisms are typically associated with persistent hyperinsulinemia and hyperglycemia. Two hundred persons who were diagnosed with type 2 diabetes were included in the example. Experts gave their approval to the review that was used to collect data. Microsoft Succeed 2020 and SPSS v. 25 were used to break down both mathematical and direct elements. In India's urban areas, there was a 2.50% recurrence of type 2 diabetes mellitus. With a standard deviation of 11.6 years, the typical age was 67.5 years. Patients with 6-11 years of diabetes had a 40% expanded hazard of creating ongoing issues; 70% worked all day; 49% did no extra vivacious work; the typical glycated hemoglobin level was 7%; and 60% of the patients were female. An expanded gamble of Type 2 Diabetes Mellitus' persevering through entanglements is related with more established age gatherings and the illness' movement after some time. Lately, type 2 diabetes has become one of the main contributors of the increasing death rates associated with A significant duration of diabetes development and stable problems are typically contrasted, with a Chi square of 67.5 and a p-value of 0.000. This study aims to identify the precise mechanisms by which modern type 2 diabetes medications reduce insulin resistance, enhance cardiovascular outcomes, and lower oxidative pressure.

Treatment ApprovalMechanism of Diabetes MellitusType-2 DiabetesCardiovascular
1,785 views
594 downloads

Contributors:

 Arnav Roy
,
 Rashmi chanda